STADA Arzneimittel Profile

USD 0.00  0.00%

STADA Arzneimittel Summary

STADA Arzneimittel Aktiengesellschaft (STDAF) is traded on OTC Market in USA. It is located in Stadastrasse 2-18 and employs 10,126 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.85 B. STADA Arzneimittel Aktiengesellschaft has 62.26 M outstanding shares. STADA ARZNEIMI NA has accumulated about 328.21 M in cash with 330.83 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.27.
Check STADA Arzneimittel Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 94.05HorizonTargetOdds Above 94.05
0.00%30 days 94.05 50.00%
Based on normal probability distribution, the odds of STADA Arzneimittel to move above current price in 30 days from now is about 50.0% (This STADA Arzneimittel Aktiengesellschaft probability density function shows the probability of STADA Arzneimittel Stock to fall within a particular range of prices over 30 days) .

Top Holders

STADA Arzneimittel A Risk Profiles

Key Fundamentals

STADA Arzneimittel Against Markets

Current Ratings

STADA Arzneimittel 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for STADA Arzneimittel Aktiengesellschaft are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare Holding GmbH. STADA Arzneimittel operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. It employs 10126 people. more
NameSTADA Arzneimittel Aktiengesellschaft
ChairmanMartin AbendView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressStadastrasse 2-18
ExchangeOTC Market
49 6101 603 0
CurrencyUSD - US Dollar


STADA Arzneimittel Corporate Management
Carl Oetker Member of the Supervisory Board
JanNicolas Garbe Member of the Supervisory Board
Dieter Koch Member of the Supervisory Board
Eckhard Brueggemann Member of the Supervisory Board, Ph.D
Also please take a look at World Market Map. Please also try CEO Directory module to screen ceos from public companies around the world.